The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
“What has been achieved in tissue engineering and regenerative medicine?” Tissue engineering and organ regeneration expert, Ekaterine Berishvili, discusses the progress, opportunities and challenges of regeneration and repair in organ transplantation.
EPITA, the scientific community dedicated to islet and pancreas transplantation, is more vibrant and productive than ever!
While preparations for the 12th EPITA Symposium & 41st AIDPIT Workshop are underway, we would like to say a BIG thank you to all our sponsors for their support. THANK YOU. #ESOT_EPITA
Update on our 12th EPITA Symposium & 41st AIDPIT Workshop! You can now find the final programme including Oral Presentations here. #ESOT_EPITA
This handbook formalises the processes associated with the preparation of ESOT CPGs, including selecting topics for new guidelines, writing and reviewing approval, dissemination, and updating. Moreover, it defines the governance of the process.
EPITA encourages applications from either diabetes physicians or nephrologists with an interest in Beta Cell Replacement Therapy or transplant surgeons.
EPITA, the European Pancreas and Islet Transplant Association, wishes to announce a call for nominations for a new Board member. The mandate of the new EPITA Board Member is 4 years (2021-2025). Given the current composition of the EPITA Board, and to ensure that all relevant specialties are represented, applications from diabetes (transplant) physicians will be
On March 5th 2021, ESOT opened a tender for a technical provider that will build the multi-organ registry. ESOT is seeking the support of additional European national authorities and expect to finalise agreement with participating countries by the end of April 2021. In addition, ESOT is establishing contacts with non-European countries and registries. read more
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
